Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06687616 · ClinicalTrials.gov registry record · NA
RCT of VR Therapy for IBS
A NA study, sponsored by Christopher Almario.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT06687616 is a NA study that has completed, run by Christopher Almario. The registered enrollment target is 73 participants.
The verdict
NCT06687616, a NA study, has completed, sponsored by Christopher Almario.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a virtual reality (VR) cognitive behavioral therapy (CBT) program versus sham VR among patients with irritable bowel syndrome (IBS). It is hypothesized that using VR-administered CBT may reduce abdominal pain, leading to improved overall physical, psychological, and social functioning when compared to sham VR.
Interventions
- DEVICE Sham VR
- DEVICE SynerGI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2025-11-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06687616
The ClinicalTrials.gov registry entry for NCT06687616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christopher Almario, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham VR is the first listed.
NCT06687616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06687616 about?
NCT06687616 is a clinical study titled "RCT of VR Therapy for IBS". Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a virtual reality (VR) cognitive behavioral therapy (CBT) program versus sham VR among patients with irritable bowel syndrome (IBS). It is hypothesized that using VR-administered CBT may redu...
What is the current status of trial NCT06687616?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2025-02-26. Estimated completion is 2025-11-25.
What interventions are being tested in trial NCT06687616?
The interventions under investigation include: Sham VR (DEVICE), SynerGI (DEVICE).
Who is sponsoring clinical trial NCT06687616?
This trial is sponsored by Christopher Almario, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.